RMIX dropped 9% over the past week, the sharpest single-week pullback since its recent run-up, and the move follows a punishing earnings day on August 14 when the stock fell more than 6% in a single session.
The earnings reaction is the clearest starting point here. A prior note flagged that RMIX had rallied 27% into Q2 results on the back of beats and raised guidance — this week's price action looks like that optimism getting unwound. The stock now trades at $17.53, down roughly 10% over the past month, giving back a meaningful chunk of the summer's gains. With no next earnings event flagged in the data, the stock is in a period where price discovery happens through positioning shifts rather than hard catalysts.
The borrow market tells a relatively relaxed story for a stock that just sold off hard. Availability has actually loosened over the past week — it climbed from around 126% to 163%, well clear of the tight zone. Cost to borrow eased slightly to 3.52%, its lowest point in roughly six weeks and well below the 4.5–4.7% range seen in early July. Short interest in share terms dipped nearly 7% in a single day on August 18, and is down about 2% on the week even as it remains around 12% above where it was a month ago. That monthly build suggests some shorts positioned ahead of earnings — and Tuesday's jump-off looks like partial cover post-print. The ORTEX short score has eased from a peak of 66.8 on August 6 to 60.8 now, moving in the right direction for longs but still elevated enough to keep the borrow story worth watching.
Analyst conviction has not buckled despite the share price weakness. B. Riley Securities reiterated its Buy rating this week, the most recent action on record, though it trimmed its target from $26 to $25 — a modest acknowledgment of the post-earnings reset. The mean price target across the analyst group sits at $23.17, implying roughly 32% upside from current levels. The coverage picture is notably bullish: B. Riley, Baird, Roth Capital, William Blair, and Jefferies all initiated since May with Buy or Outperform ratings. None have cut to Neutral or Sell. On valuation, the PE multiple has compressed sharply — down nearly 24% over the past month to just under 47x — as the price has pulled back. EV/EBITDA is tracking similarly lower at 16.1x, off about 3% in a week. The price-to-book at 3.8x has also softened around 6% over 30 days.
The ownership structure is worth noting for context on the institutional makeup. SunTx Capital Management holds 33% of shares, making it a dominant anchor. Fidelity (FMR) holds just under 10%, and Harraden Circle — which spent April selling aggressively, offloading more than $6.3 million of stock at prices around $12.50 to $13.10 — still holds nearly 7% of shares outstanding. That insider selling at lower prices than today's levels is worth filing away: Harraden was trimming at $12.50 when the stock has since traded above $19. The most recent insider data is four months stale, so the current state of that position is unclear, but the April selling trajectory was notable.
Among correlated peers, US-listed TTAM dropped 5.4% on the week and AIM-listed SRC fell 6.9% — both broadly tracking the same direction as RMIX, suggesting the construction materials sector is seeing broader softness rather than a purely company-specific move. That sectoral read takes some of the sting out of the post-earnings drop but doesn't fully explain the magnitude of the RMIX move.
What to watch next: whether the B. Riley target trim proves to be the first in a sequence of analyst resets, and whether the loosening availability and short cover seen this week continues — or reverses — as the post-earnings dust settles and the stock finds a new equilibrium.
See the live data behind this article on ORTEX.
Open RMIX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
